Status:
NOT_YET_RECRUITING
Locoregional Recurrence of Breast Cancer
Lead Sponsor:
Assiut University
Conditions:
Locoregional Recurrence
Eligibility:
All Genders
18+ years
Brief Summary
our study will be retrospective on breast cancer patients to detect relation between the locoregional recurrence of breast cancer after radiotherapy and the molecular subtypes
Detailed Description
Having replaced lung cancer as the most common cancer globally, breast cancer today represent 1 in 8 cancer cases and a total of 2.3 million new cases in both sexes . It Represents a quarter of all c...
Eligibility Criteria
Inclusion
- Age ≥ 18
- Male or female
- Histological proven breast cancer (IDC / ILC)
- with known receptor status
- Patient did mastectomy or breast conservative surgery +/- lymph node dissection .
- received radiotherapy
- on regular follow up
Exclusion
- Metastatic from the start (stage 4)
Key Trial Info
Start Date :
August 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
265 Patients enrolled
Trial Details
Trial ID
NCT05988112
Start Date
August 1 2024
End Date
September 1 2025
Last Update
July 16 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.